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Protein molecular modeling shows residue T599 is critical to
wild-type function of POLG and description of a novel variant
associated with the SANDO phenotype
John E Richter1, Hector G Robles2, Elizabeth Mauricio3, Ahmed Mohammad1, Paldeep S Atwal1 and Thomas R Caulfield4,5,6
Sensory ataxic neuropathy with dysarthria and ophthalmoparesis (SANDO) is a rare phenotype resulting from pathogenic variants
of mitochondrial DNA polymerase gamma (POLG). We modeled a novel POLG variant, T599P, that causes the SANDO phenotype
and another variant at the same residue, p.T599E, to observe their effect on protein function and confirm the pathogenicity of
T599P. Through neoteric molecular modeling techniques, we show that changes at the T599 residue position introduce extra
rigidity into the surrounding helix–loop–helix, which places steric pressure on nearby nucleotides. We also provide a clinical
description of the T599P variant, which was found in a 42-year-old female proband. The proband presented a 1-year history of
progressive gait instability, dysarthria and foot numbness. Her neurologic examination revealed ataxic dysarthria, restricted eye
movements, head and palatal tremors, reduced lower limb reflexes, distal multimodal sensory loss and a wide, unsteady ataxic gait.
Electromyography studies indicated a sensory neuropathy. Whole-exome sequencing was pursued after tests for infectious,
inflammatory and paraneoplastic causes were negative.
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INTRODUCTION
An array of mitochondrial disorders has been linked to pathogenic
variants in POLG, which encodes mitochondrial DNA (mtDNA)
polymerase gamma (POLG). The integrity of this protein is crucial
to mtDNA stability and replication, as pathogenic variants often
cause mtDNA deletions or depletions.1 POLG pathogenic variants
have been associated with several disease phenotypes, including
myoclonic epilepsy myopathy sensory ataxia, autosomal recessive
and dominant forms of progressive external ophthalmoplegia, and
the ataxia neuropathic spectrum.2 The ataxia neuropathic
spectrum includes sensory ataxic neuropathy with dysarthria
and ophthalmoparesis (SANDO), a rare phenotype that has only
been recorded in a small number of clinical cases.1
mtDNA depletion in both skeletal muscle and peripheral nerve
tissue stems from certain pathogenic variants of POLG, resulting in
dysfunctional mitochondria and the clinical triad of sensory ataxic
neuropathy, dysarthria and ophthalmoparesis.3 In this report, we
model a novel POLG variant that causes a SANDO phenotype,
T599P, and another variant at the same residue, p.T599E, to
observe their effect on protein function and to confirm the
pathogenicity of T599P. We describe a proband with the T599P
variant found in the linker domain (amino acid residues 418–755)
of POLG.4 We propose that this pathogenic variant correlates with
the SANDO condition.
MATERIALS AND METHODS
Using genomic DNA from the submitted specimen, the exonic regions and
flanking splice junctions were captured using a proprietary system
developed by GeneDx and then were sequenced by massively parallel
(NextGen) sequencing on an Illumina system with 100 bp or greater
paired-end reads. Reads were aligned to the human genome build
GRCh37/UCSC hg19 and analyzed for sequence variants using a custom
analysis tool (Xome Analyzer). Capillary sequencing or another appropriate
method was used to confirm all potentially pathogenic variants identified
in this individual. Sequence alterations were reported according to the
Human Genome Variation Society nomenclature guidelines.
The entire mitochondrial genome from the submitted sample was
amplified and sequenced using a solid-state sequencing by-synthesis
process. The DNA sequence was assembled and analyzed in comparison to
the revised Cambridge Reference Sequence and the reported variants and
polymorphisms listed in the MITOMAP database (http://www.mitomap.
org). The presence of a disease-associated sequence variant was confirmed
by conventional dideoxy sequence analysis or other methods. A reference
library of more than 6,000 samples from different ethnic groups and online
databases of mtDNA variations was used to evaluate variants of unknown
clinical significance.
The sequence of human DNA polymerase subunit gamma-1 (POLG), a
protein encoded by POLG, was taken from the NCBI Reference Sequence
NM_002693.2: NP_002684.1 and used for computer-assisted modeling.
Monte Carlo simulations were performed on the mutant to allow local
regional changes after the p.T599P and p.T599E variants were introduced.
The X-ray refinement for Monte Carlo was built using the YASARA SSP/
PSSM method.5–10 The structure was relaxed to the YASARA/Amber force
field using knowledge-based potentials within YASARA. The side chains
and rotamers were adjusted with knowledge-based potentials, simulated
annealing with an explicit solvent and small equilibration simulations using
YASARA’s refinement protocol.11 The entire full-length structure was
modeled, and gaps or unresolved portions were filled from the X-ray.
Refinement of the finalized models was completed using either
Schrodinger’s LC-MOD Monte Carlo-based module or NAMD2 protocols.
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These refinements started with an initial refinement and the mutants
T599P and T599E, generated by YASARA.5–7,9 The superposition and
subsequent refinement of the overlapping regions yielded a complete
model of POLG. The final structures were subjected to energy optimization
with a PR conjugate gradient with an R-dependent dielectric.
The atom consistency was checked for all 1,239 amino acids to verify the
correct chain name, dihedrals, angles, torsions, non-bonds, electrostatics,
atom-typing and parameters. Each model was exported to the following
programs: Maestro (MAE); and YASARA (PDB). Model manipulation was
done with Maestro (Macromodel, version 9.8, Schrodinger, LLC, New York,
NY, USA) or Visual Molecular Dynamics.12
Monte Carlo dynamics searching (LCMOD-MC) was completed on each
model for conformational sampling using methods described in the
literature.13–16 Briefly, each POLG variant system was minimized with
relaxed restraints using either Steepest Descent or Conjugate Gradient PR
then allowed to undergo the Monte Carlo search criteria, as described in
the literature.13–16 The primary purpose of Monte Carlo was to examine the
conformational variability from different mutations in the region near the




For p.T599P, we found the energetic ΔΔG shift to be
+0.401813 kcal/mol Å2, which would increase the energy within
the local region compared to the wild type.13–15,17–20 Local
residues within the 6 Å cutoff under the influence of the mutation
include Leu466, Ser592, Gln595, Met596, Arg597, Pro600, Lys601,
Glu616, Arg617 and Phe766. The effects of the energetic changes
included increased rigidity and directional reorientation of the
loop segment from the loop–helix–loop, which promoted inter-
actions between Gln595 and the phenylalanines adjacent to the
DNA-binding regions. The entire region changes in root mean
square deviation of the side chain atoms was 4.3813 Å. The
maximum difference between atom pairs for the phenylalanine
(Phe766) ring atoms was 13.7707 Å, although Gln595 was
significantly altered. Gln595 and Phe766 may significantly alter
DNA-binding efficiency, whereas the double prolines (Pro599 and
Pro600) changed the orientation of the loop between the helices
shown (Figure 1). Thus, the reoriented side chains may weaken or
alter the process of DNA binding, whereas “rigidifying” the loop
may render it less able to accommodate induced fit protein
flexibility that occurs during substrate binding.
In addition, we modeled a different residue change at position
599, denoted p.T599E, to observe its effect and confirm that this
conserved residue is important for wild-type POLG function.
Molecular modeling of the p.T599E variant was performed,
and Monte Carlo simulations suggested that the orientation of
the T and E residues flip. The mutant may disrupt other POLG
protein chains from binding and lead to changes in the helix–
loop–helix conformation, where E599 is present in the middle of
the loop (Figure 2). We found the energetic ΔΔG shift to be
− 0.506754 kcal/mol Å2, which, from a modeling perspective,
favors this variant over the wild type for the stabilization of local
amino-acid residues.13–15,17–20
Clinical description
A 42-year-old woman presented to our clinic with symptoms,
including worsening gait instability, dysarthria and foot numbness
of over a 1-year duration. She was first referred to our
neurogenetics clinic after consulting several neurologists who
were unable to determine an acquired cause for her symptoma-
tology. Her neurologic examination revealed an ataxic dysarthria,
restricted eye movements, inability to maintain fixation and head
and palatal tremors. Her strength was normal, but she had
reduced lower limb reflexes and distal multimodal sensory loss.
Her gait was wide and unsteady, and she was unable to stand
without support.
Electromyography revealed reduced or absent sensory
responses and normal motor responses. Her concentric needle
examination was consistent with a sensory neuropathy or
neuronopathy. A brain magnetic resonance imaging scan showed
hypertrophic olivary degeneration and T2 hyperintense signal
abnormalities in the cerebellar hemispheres, thalami and bilateral
basal ganglia (Figure 3). Spinal cord imaging was unremarkable.
Negative laboratory studies included a complete blood count,
chemistry panel, vitamin B12, sedimentation rate, hemoglobin
Figure 1. Schematic representation (three-dimensional molecular representation) of DNA polymerase gamma (POLG) side chain interactions
within the local region and the T599P variant as well as its effect on DNA enzymatic processes. DNA is shown with cyan carbons and POLG
with gray carbons.
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A1c, creatine kinase, thyroid profile, antinuclear antibody,
extractable nuclear antigen evaluation, angiotensin-converting
enzyme, serum protein electrophoresis, Lyme, serologies for HTLV
I and II, and HIV, and Tropheryma whipplei PCR. A cerebrospinal
fluid examination was normal, including cell count and protein
and glucose levels, and the patient was negative for oligoclonal
bands. Her electroencephalogram was normal. Following these
tests, the patient was referred to neurogenetics where whole-
exome sequencing and mtDNA analysis were ordered due to the
suspected mitochondrial disease.
WES results indicated that the patient was homozygous for a
variant of unknown significance, c.1795 A4C (p.T599P), in exon 10
of POLG. Because this substitution is non-conservative and alters
the polarity of amino-acid residue 599, in silico prediction software
showed that it likely damages the structure of the POLG protein.
Using the PolyPhen-2 bioinformatics tools, the T599P variant was
predicted to be “probably damaging”, with a score of 0.999.
PolyPhen-2 predicts the effect of a single amino-acid substitution
on the function of human proteins.21
In addition, no causative variants in disease genes associated
with the patient’s phenotype were found, and mtDNA testing was
normal. Negative POLG deletion and duplication tests, as well as
an absence of the condition in other family members (Figure 4),
indicated that the variant was novel and caused an autosomal
recessive mitochondrial disease with the SANDO phenotype.
DISCUSSION
POLG pathogenic variants have heterogeneous phenotypes due to
the vital importance of POLG, the only enzyme capable of
replicating and repairing mitochondrial DNA in humans. If an
individual is unable to produce wild-type POLG, respiratory chain
complex I, III, IV and V dysfunction occurs, as a number of proteins
in each complex is encoded by mtDNA. Mutant POLG often
displays reduced mtDNA replication, leading to deletions or
depletions of the mtDNA required to produce the complexes.
Incomplete respiratory chain complexes inhibit proper ATP
synthesis and cause a deficiency in energy metabolism.4 This, in
turn, produces a variety of disease phenotypes, of which SANDO is
only one example.2 SANDO remains a rare and challenging
diagnosis, demonstrated in a small subset of 20+ patients since it
was first described in 1997.3
Our particular patient has a novel pathogenic variant in POLG,
which adds to the variant spectrum of this condition. This variant
is not present in the Exome Aggregation Consortium database22 in
either a heterozygous or homozygous state, demonstrating its
uncommon nature in humans. Despite the uniqueness of this
variant, it appears to result in a rather pedestrian SANDO
symptomatology. The proband displays the classic symptoms of
sensory ataxia neuropathy, dysarthria and ophthalmoplegia. The
magnetic resonance imaging brain scan revealed signs of
encephalopathy, a known symptom of the phenotype, but
curiously, the proband did not present a history of seizures that
often accompanies such degeneration. It is possible that the
seizures will appear in time, considering the relatively short history
of symptoms our proband has experienced. Aside from this small
deviation, she appears to present the classic SANDO phenotype.2
Interestingly, p.T599P is the sole pathogenic variant found in
our patient and lies in the linker domain of POLG. This domain has
only been reported as causing SANDO without accompanying
exonuclease or polymerase domain pathogenic variants in a few
patients with the well-recognized p.A467T pathogenic variant.23,24
When one considers the high conservation rate of the linker
domain and that its pathogenic variants cause phenotypes
including the often fatal Alpers–Huttenlocher syndrome, the
harmful nature of this new variant is not surprising.25 Overall,
our investigation supports the concept that linker domain
pathogenic variants are as capable of causing the usual symptoms
of SANDO as the exonuclease or polymerase domain pathogenic
variants.
Molecular modeling of the p.T599P variant was performed, and
Monte Carlo simulations suggest that the introduction of proline
induces a backbone dihedral adjustment of 135°. This adjustment
significantly alters the orientation of the helix–loop–helix motif
that is immediately adjacent to binding DNA (Figure 1). These
conformational changes in the loop affect helix interactions with
Figure 2. Schematic representation (three-dimensional molecular representation) of DNA polymerase gamma (POLG) side chain interactions
within the local region and the T599E variant, as well as its effect on DNA enzymatic processes. DNA is shown with cyan carbons and POLG
with gray carbons.
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P599 and the adjacent DNA nucleotides that are effectively
displaced. The energetics calculations show that the directly
neighboring residues are further affected by the p.T599P variant
compared with the wild type. The impact is twofold: there is an
increased rigidity with the helix–loop–helix motif due to the
double prolines at 599 and 600, and the side chains that have
altered conformations (most importantly the Q595 and F766) are
adjacent to DNA nucleotides under increased van der Waals
forces, which may decrease nucleotide-binding efficiency.
Molecular modeling of the p.T599E variant suggests that the
orientation of the T and E residues are flipped. These conforma-
tional changes in the loop affect helix interactions with E599 and
the adjacent DNA nucleotides that have shifted. The energetics
calculations show that the directly neighboring residues are
further stabilized with the p.T599E variant compared to the wild
type. This change may increase the rigidity between the helix–
loop–helix motif, which increases the van der Waals forces on the
adjacent DNA nucleotides, resulting in the slight nucleotide
Figure 3. Axial T2 magnetic resonance imaging brain scan demonstrates bilateral, symmetrical hyperintense, hypertrophic olivary
degeneration (O) and symmetrical bands of hyperintensity (arrows) in the cerebellar hemispheres.
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deviation observed. The extra rigidity in the local 6 Å region may
alter the function of the flexible loop segment.
These molecular data demonstrate the importance of T599 in
wild-type POLG function and support the observation that this
residue is highly conserved across species.
There was a lengthy diagnostic odyssey involving multiple
specialists at different institutes before a definite cause was
determined for the patient’s condition. The hunt for an acquired
cause of her symptoms resulted in multiple expensive and
invasive tests (such as lumbar puncture), which may have been
avoided with early genetic testing. This case highlights that whole-
exome sequencing is a valuable tool by which new pathogenic
variants can be identified, as this form of testing revealed the
patient’s condition. We demonstrate that if a novel variant of
unknown significance is identified, we can perform neoteric
functional protein modeling to evaluate the effect on protein
dynamics and subsequently use this information to aid in a clinical
diagnosis. In addition, we demonstrate the importance of
considering SANDO when patients present the triad symptoms
of sensory neuropathy, dysarthria and ophthalmoparesis. In similar
cases, whole-exome sequencing could be performed first to
truncate costs and time between presentation and diagnosis
when this difficult constellation of symptoms is recognized.
In summary, we demonstrate a novel protein modeling method
for variant interpretation of a POLG variant of unknown
significance that can be expanded and used for other genetic
conditions and protein variants. In addition, this process can be
used to determine why particular protein residues are conserved
across species.
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